No matter how cynical the overall market is Integra Lifesciences Holdings Corp (IART) performance over the last week is recorded -11.50%

As on Thursday, Integra Lifesciences Holdings Corp (NASDAQ: IART) got off with the flyer as it spiked 0.37% to $21.78, before settling in for the price of $21.70 at the close. Taking a more long-term approach, IART posted a 52-week range of $21.67-$45.42.

The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 1.17%. Meanwhile, its Annual Earning per share during the time was 3.10%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -19.49%. This publicly-traded company’s shares outstanding now amounts to $78.17 million, simultaneously with a float of $65.24 million. The organization now has a market capitalization sitting at $1.69 billion. At the time of writing, stock’s 50-day Moving Average stood at $28.92, while the 200-day Moving Average is $35.02.

Integra Lifesciences Holdings Corp (IART) Ownership Facts and Figures

Another important factor to analyze is how key investors are playing towards the stock of the Medical Devices industry. Integra Lifesciences Holdings Corp’s current insider ownership accounts for 15.91%, in contrast to 83.86% institutional ownership. According to the most recent insider trade that took place on May 23 ’24, this organization’s Exec. Chairman of the Board bought 52,641 shares at the rate of 28.49, making the entire transaction reach 1,499,979 in total value, affecting insider ownership by 487,922. Preceding that transaction, on May 21 ’24, Company’s Director bought 36,350 for 27.40, making the whole transaction’s value amount to 995,816. This particular insider is now the holder of 36,350 in total.

Integra Lifesciences Holdings Corp (IART) Earnings and Revenue Records

Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.87 per share during the current fiscal year.

Integra Lifesciences Holdings Corp’s EPS decrease for this current 12-month fiscal period is -19.49% and is forecasted to reach 2.57 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 6.30% through the next 5 years, which can be compared against the 3.10% growth it accomplished over the previous five years trading on the market.

Integra Lifesciences Holdings Corp (NASDAQ: IART) Trading Performance Indicators

Let’s observe the current performance indicators for Integra Lifesciences Holdings Corp (IART). It’s Quick Ratio in the last reported quarter now stands at 2.10. The Stock has managed to achieve an average true range (ATR) of 1.44. Alongside those numbers, its PE Ratio stands at $73.81, and its Beta score is 1.12. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.08. Similarly, its price to free cash flow for trailing twelve months is now 28.69.

In the same vein, IART’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.30, a figure that is expected to reach 0.39 in the next quarter, and analysts are predicting that it will be 2.57 at the market close of one year from today.

Technical Analysis of Integra Lifesciences Holdings Corp (IART)

Through scrutinizing the latest numbers posted by the [Integra Lifesciences Holdings Corp, IART], it can be observed that its last 5-days Average volume of 1.3 million was better the volume of 1.17 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 3.93% While, its Average True Range was 1.50.

Raw Stochastic average of Integra Lifesciences Holdings Corp (IART) in the period of the previous 100 days is set at 1.72%, which indicates a major fall in contrast to 2.19% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 88.20% that was higher than 60.74% volatility it exhibited in the past 100-days period.